Mario Gabelli's ABBV Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 15,252 shares of AbbVie Inc. (ABBV) worth $3.48 M, representing 0.03% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Mario Gabelli has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2014, adding 24,175 shares. Largest reduction occurred in Q3 2016, reducing 15,100 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -16 | Reduce 0.10% | 15,252 | $228.48 |
| Q3 2025 | -482 | Reduce 3.06% | 15,268 | $231.53 |
| Q2 2025 | +2,402 | Add 18.00% | 15,750 | $185.62 |
| Q1 2025 | -189 | Reduce 1.40% | 13,348 | $209.52 |
| Q4 2024 | -76 | Reduce 0.56% | 13,537 | $177.70 |
| Q3 2024 | -1,138 | Reduce 7.71% | 13,613 | $197.48 |
| Q2 2024 | +475 | Add 3.33% | 14,751 | $171.52 |
| Q1 2024 | -955 | Reduce 6.27% | 14,276 | $182.10 |
| Q4 2023 | -1,024 | Reduce 6.30% | 15,231 | $154.97 |
| Q3 2023 | -15 | Reduce 0.09% | 16,255 | $149.06 |
| Q2 2023 | -3,147 | Reduce 16.21% | 16,270 | $134.73 |
| Q1 2023 | -665 | Reduce 3.31% | 19,417 | $159.37 |
| Q4 2022 | +498 | Add 2.54% | 20,082 | $161.61 |
| Q3 2022 | +1,342 | Add 7.36% | 19,584 | $134.19 |
| Q2 2022 | -911 | Reduce 4.76% | 18,242 | $153.16 |
| Q1 2022 | -1,683 | Reduce 8.08% | 19,153 | $162.12 |
| Q4 2021 | -3,916 | Reduce 15.82% | 20,836 | $135.39 |
| Q3 2021 | +3,122 | Add 14.43% | 24,752 | $107.87 |
| Q2 2021 | +67 | Add 0.31% | 21,630 | $112.62 |
| Q1 2021 | +813 | Add 3.92% | 21,563 | $108.24 |
| Q4 2020 | -7,095 | Reduce 25.48% | 20,750 | $107.13 |
| Q3 2020 | -12,384 | Reduce 30.78% | 27,845 | $87.59 |
| Q2 2020 | +9,401 | Add 30.50% | 40,229 | $98.19 |
| Q1 2020 | +4,821 | Add 18.54% | 30,828 | $76.20 |
| Q4 2019 | +589 | Add 2.32% | 26,007 | $88.55 |
| Q3 2019 | +15,435 | Add 154.61% | 25,418 | $75.73 |
| Q2 2019 | +1,219 | Add 13.91% | 9,983 | $72.72 |
| Q1 2019 | +864 | Add 10.94% | 8,764 | $80.56 |
| Q4 2018 | +150 | Add 1.94% | 7,900 | $92.15 |
| Q3 2018 | -10,435 | Reduce 57.38% | 7,750 | $94.58 |
| Q2 2018 | -452 | Reduce 2.43% | 18,185 | $92.66 |
| Q1 2018 | -70 | Reduce 0.37% | 18,637 | $94.65 |
| Q4 2017 | -141 | Reduce 0.75% | 18,707 | $96.70 |
| Q3 2017 | -425 | Reduce 2.21% | 18,848 | $88.87 |
| Q2 2017 | -103 | Reduce 0.53% | 19,273 | $72.48 |
| Q1 2017 | -700 | Reduce 3.49% | 19,376 | $65.18 |
| Q4 2016 | -120 | Reduce 0.59% | 20,076 | $62.61 |
| Q3 2016 | -15,100 | Reduce 42.78% | 20,196 | $63.08 |
| Q2 2016 | -164 | Reduce 0.46% | 35,296 | $61.91 |
| Q1 2016 | -5,140 | Reduce 12.66% | 35,460 | $57.11 |
| Q4 2015 | -3,330 | Reduce 7.58% | 40,600 | $59.24 |
| Q3 2015 | -2,632 | Reduce 5.65% | 43,930 | $54.40 |
| Q2 2015 | -650 | Reduce 1.38% | 46,562 | $67.20 |
| Q1 2015 | +12,655 | Add 36.62% | 47,212 | $58.54 |
| Q4 2014 | +24,175 | Add 232.85% | 34,557 | $65.43 |
| Q2 2014 | -80 | Reduce 0.76% | 10,382 | $56.44 |
| Q1 2014 | +382 | Add 3.79% | 10,462 | $51.42 |
| Q2 2013 | +10,080 | Add 0.00% | 10,080 | $41.37 |
Mario Gabelli's AbbVie Investment FAQs
Mario Gabelli first purchased AbbVie Inc. (ABBV) in Q2 2013, acquiring 10,080 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held AbbVie Inc. (ABBV) for 51 quarters since Q2 2013.
Mario Gabelli's largest addition to AbbVie Inc. (ABBV) was in Q4 2014, adding 34,557 shares worth $2.26 M.
According to the latest 13F filing for Q4 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 15,252 shares of AbbVie Inc. (ABBV), valued at approximately $3.48 M.
As of the Q4 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.03% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in AbbVie Inc. (ABBV) was 47,212 shares, as reported at the end of Q1 2015.